(11-283) Effectiveness of Fixed 4 Factor Prothrombin Complex Concentrate (human) Dosing in the Reversal of Apixaban and Rivaroxaban Associated Bleeding: A Retrospective Analysis
Wednesday, December 7, 2022
12:30 PM – 1:30 PM
Location: Bayside A, Level 1
Category: Research-in-Progress Topic: Emergency Medicine
Primary Author(s)
Emma Webster, PharmD
Resident Pharmacist Champlain Valley Physicians Hospital, New York
